Immune checkpoint inhibitors in gastrointestinal malignancies: an Umbrella review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Immune checkpoint inhibitors in gastrointestinal malignancies: an Umbrella review ; volume:24 ; number:1 ; day:5 ; month:1 ; year:2024 ; pages:1-29 ; date:12.2024
Cancer cell international ; 24, Heft 1 (5.1.2024), 1-29, 12.2024
- Urheber
-
Noori, Maryam
Jafari-Raddani, Farideh
Davoodi-Moghaddam, Zeinab
Delshad, Mahda
Safiri, Saeid
Bashash, Davood
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-023-03183-3
- URN
-
urn:nbn:de:101:1-2024031821364660601260
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Noori, Maryam
- Jafari-Raddani, Farideh
- Davoodi-Moghaddam, Zeinab
- Delshad, Mahda
- Safiri, Saeid
- Bashash, Davood
- SpringerLink (Online service)
Ähnliche Objekte (12)
Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
Hematologic malignancies following immune checkpoint inhibition for solid tumors
Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor
Role of immune checkpoint inhibitors in gastrointestinal cancer treatment
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
Checkpoint inhibitors in hematological malignancies
Immunotherapeutic advances in gastrointestinal malignancies
CRISPR/Cas9 in Gastrointestinal Malignancies
Hyperfractionated abdominal reirradiation for gastrointestinal malignancies
Advances in molecular imaging of immune checkpoint targets in malignancies: current and future prospect
Reirradiation to the abdomen for gastrointestinal malignancies
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
Hematologic malignancies following immune checkpoint inhibition for solid tumors
Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor
Role of immune checkpoint inhibitors in gastrointestinal cancer treatment
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
Checkpoint inhibitors in hematological malignancies
Immunotherapeutic advances in gastrointestinal malignancies
CRISPR/Cas9 in Gastrointestinal Malignancies
Hyperfractionated abdominal reirradiation for gastrointestinal malignancies
Advances in molecular imaging of immune checkpoint targets in malignancies: current and future prospect
Reirradiation to the abdomen for gastrointestinal malignancies
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
Hematologic malignancies following immune checkpoint inhibition for solid tumors
Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor
Role of immune checkpoint inhibitors in gastrointestinal cancer treatment
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
Checkpoint inhibitors in hematological malignancies
Immunotherapeutic advances in gastrointestinal malignancies
CRISPR/Cas9 in Gastrointestinal Malignancies
Hyperfractionated abdominal reirradiation for gastrointestinal malignancies
Advances in molecular imaging of immune checkpoint targets in malignancies: current and future prospect
Reirradiation to the abdomen for gastrointestinal malignancies